Sleep device giant ResMed says it expects to benefit from Donald Trump’s trade tariffs and tax cuts if competitors making rival products in China and Mexico are slapped with additional duties when they import devices into the United States.
ResMed chief executive Mick Farrell said on Friday there were early signs the Trump administration would be a positive for medical technology companies as a whole with tax cuts introduced in 2017 expected to be extended under the new president.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。